Company: MSTR
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100720
Chunk: 67

Company: Strategy Inc
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 67
---
 by the Company or resigns for “good reason,” in each case as defined in the applicable option agreement, within 12 months following the change in control event or if the acquiring company does not assume the options or substitute equivalent awards. If such a change in control event had occurred on December 31, 2024, and the specified conditions as set forth in the applicable option agreement were satisfied:

| • |     | vesting of the options held by Mr. Le would have been accelerated with respect to (i) 100,000 shares granted in February 2021, representing a benefit of $22,049,700, based on the difference between $69.123, the exercise price per share of the option, and $289.62, the closing price of our Class A Stock on Nasdaq on December 31, 2024 (ii) 200,000 shares granted in February 2022, representing a benefit of $49,832,000, based on the difference between $40.46, the exercise price per share of the option, and $289.62, the closing price of our Class A Stock on Nasdaq on December 31, 2024, (iii) 300,000 shares granted in September 2022, representing a benefit of $79,948,500, based on the difference between $23.125, the exercise price per share of the option, and $289.62, the closing price of our Class A Stock on Nasdaq on December 31, 2024; and (iv) 26,730 shares granted in March 2024, representing a benefit of $3,466,640, based on the difference between $159.929, the exercise price per share of the option, and $289.62, the closing price of our Class A Stock on Nasdaq on December 31, 2024; no portion of the remaining options held by Mr. Le would have been subject to accelerated vesting because, with respect to the option granted in 2019, the remaining shares underlying such option were already fully vested as of December 31, 2024; |

| • |     | vesting of the options held by Mr. Kang would have been accelerated with respect to (i) 75,000 shares granted in May 2022, representing a benefit of $20,240,700, based on the difference between $19.744, the exercise price per share of the option, and $289.62,